PMDA — authorised 23 March 2018
- Marketing authorisation holder: Chugai Pharmaceutical Co., Ltd.
- Status: approved
🇯🇵 Hemlibra in Japan
PMDA authorised Hemlibra on 23 March 2018
Marketing authorisation
Hemlibra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Hemlibra approved in Japan?
Yes. PMDA authorised it on 23 March 2018.
Who is the marketing authorisation holder for Hemlibra in Japan?
Chugai Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.